Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Markets
Stocks
Sectors
Investing Tools
Overview
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
SAVIENT PHARMA (NQ: SVNT)
+0.3600 (+2.892%)
at
12.81
743,141 in Volume
Add to:
My Watchlist
Data as of 08:10 PM EST Feb 9,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 12.65
Bid (Size) 12.77 (20100)
Ask (Size) 12.81 (8900)
Prev. Close 12.45
Today's Range 12.46 - 12.95
52wk Range 3.450 - 16.62
Shares Outstanding 66,626,296
Morningstar Profile
View Full Profile
SAVIENT PHARMA
The Company and its subsidiaries are focused on developing and marketing pharmaceutical products that target unmet medical needs in both niche and broader specialty markets. It is currently developing one product: KRYSTEXXA(tm).
Healthcare
Biotechnology
Exchange Traded NQ
Market Cap 853.48M
Related Companies SGEN CPHD PDLI VPHM
Featured News
Read More
Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
Feb 08, 2010
from PRNewsWire News Releases
Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
Jan 08, 2010
Company Completes Reversion to Phase 3 Manufacturing Process and Reaffirms 1Q 2010 Target for KRYSTEXXA BLA Resubmission Read More
from PRNewsWire News Releases
Featured News
Read More
Savient To Present at the 28th Annual JP Morgan Healthcare Conference
Dec 10, 2009
from PRNewsWire News Releases
Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
Nov 04, 2009
from PRNewsWire News Releases
Savient Pharmaceuticals to Hold Third Quarter 2009 Financial Results Conference Call on Thursday, November 5, 2009
Oct 28, 2009
from PRNewsWire News Releases
Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
Oct 15, 2009
from PRNewsWire News Releases
More News
Read More
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA